Background: Recently. modification of T cells with chimeric antigen receptor (CAR) has been an attractive approach for adoptive immunotherapy of cancers. Typically. CARs contain a single-chain variable domain fragment (scFv). https://thegreensjunglebeautyshops.shop/product-category/face-serum/